
|Articles|October 7, 2019
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
Author(s)Julianne Mobilian
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Advertisement
Denise Visco, MD, conducted a retrospective chart analysis of patients who received phenylephrine and ketorolac (OMIDRIA) during surgery-here's what she found.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5















































.png)


